ACM
RGNT

AIGH Capital Management’s Regentis Biomaterials RGNT Stock Holding History

AIGH Capital Management’s Portfolio RGNT Stock Details RGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$917K Buy
+300,000
New +$1.44M 0.13% 39

Other funds holding RGNT

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AIGH Capital Management's RGNT Position: Q1 2026 in Review

AIGH Capital Management opened a new position in Regentis Biomaterials (RGNT) in Q1 2026: 300,000 shares worth $917K. The stake represents 0.13% of the portfolio and ranks #39 among its holdings.

3 funds tracked by Wall St. Rank hold RGNT as of Q1 2026.

  • AIGH Capital Management held 300,000 shares of Regentis Biomaterials worth $917K as of Q1 2026.
  • Regentis Biomaterials was a new AIGH Capital Management position in Q1 2026.
  • Regentis Biomaterials made up 0.13% of AIGH Capital Management's portfolio in Q1 2026, its #39 holding.
  • 3 funds tracked by Wall St. Rank held Regentis Biomaterials as of Q1 2026.

Based on AIGH Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.